Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits
Condition: Proliferative Glomerulonephritis With Monoclonal IgG Deposits Intervention: Drug: Daratumumab Sponsor: Mayo Clinic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Glomerulonephritis | Research